Article
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry.
European journal of preventive cardiology - 3 Jun 2024
D'Erasmo Laura, Bini Simone, Casula Manuela, Gazzotti Marta, Bertolini Stefano, Calandra Sebastiano, Tarugi Patrizia, Averna Maurizio, Iannuzzo Gabriella, Fortunato Giuliana, Catapano Alberico L, Arca Marcello
Abstract excerpt
AIMS: The availability of novel lipid-lowering therapies (LLTs) has remarkably changed the clinical management of homozygous familial hypercholesterolaemia (HoFH). The impact of these advances was evaluated in a cohort of 139 HoFH patients followed in a real-world clinical setting. METHODS AND RESULTS: The clinical characteristics of 139 HoFH patients, along with information about LLTs and low-density lipoprotein...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
